Intrinsic value of Chemours - CC

Previous Close

$44.34

  Intrinsic Value

$1.90

stock screener

  Rating & Target

str. sell

-96%

Previous close

$44.34

 
Intrinsic value

$1.90

 
Up/down potential

-96%

 
Rating

str. sell

We calculate the intrinsic value of CC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2017), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 8.2

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046
   2047

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  14.50
  13.55
  12.70
  11.93
  11.23
  10.61
  10.05
  9.54
  9.09
  8.68
  8.31
  7.98
  7.68
  7.41
  7.17
  6.96
  6.76
  6.58
  6.43
  6.28
  6.15
  6.04
  5.94
  5.84
  5.76
  5.68
  5.61
  5.55
  5.50
  5.45
Revenue, $m
  7,080
  8,039
  9,059
  10,140
  11,279
  12,475
  13,729
  15,039
  16,406
  17,830
  19,312
  20,854
  22,456
  24,121
  25,851
  27,650
  29,519
  31,462
  33,484
  35,588
  37,779
  40,060
  42,438
  44,917
  47,503
  50,203
  53,021
  55,965
  59,041
  62,257
Variable operating expenses, $m
  7,176
  8,146
  9,178
  10,271
  11,423
  12,633
  13,901
  15,226
  16,608
  18,049
  19,531
  21,090
  22,710
  24,394
  26,144
  27,962
  29,853
  31,818
  33,863
  35,991
  38,206
  40,513
  42,918
  45,425
  48,041
  50,771
  53,621
  56,598
  59,709
  62,962
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  7,176
  8,146
  9,178
  10,271
  11,423
  12,633
  13,901
  15,226
  16,608
  18,049
  19,531
  21,090
  22,710
  24,394
  26,144
  27,962
  29,853
  31,818
  33,863
  35,991
  38,206
  40,513
  42,918
  45,425
  48,041
  50,771
  53,621
  56,598
  59,709
  62,962
Operating income, $m
  -97
  -108
  -119
  -131
  -144
  -158
  -172
  -187
  -202
  -218
  -219
  -236
  -254
  -273
  -293
  -313
  -334
  -356
  -379
  -403
  -427
  -453
  -480
  -508
  -538
  -568
  -600
  -633
  -668
  -704
EBITDA, $m
  271
  308
  347
  388
  432
  478
  526
  576
  628
  683
  739
  798
  860
  923
  990
  1,059
  1,130
  1,205
  1,282
  1,362
  1,446
  1,534
  1,625
  1,720
  1,819
  1,922
  2,030
  2,143
  2,260
  2,384
Interest expense (income), $m
  208
  230
  282
  338
  398
  461
  527
  597
  670
  746
  826
  909
  995
  1,085
  1,178
  1,275
  1,376
  1,480
  1,589
  1,703
  1,820
  1,943
  2,070
  2,203
  2,342
  2,486
  2,637
  2,794
  2,958
  3,130
  3,309
Earnings before tax, $m
  -327
  -390
  -457
  -529
  -605
  -685
  -769
  -856
  -948
  -1,044
  -1,127
  -1,231
  -1,339
  -1,451
  -1,567
  -1,689
  -1,814
  -1,945
  -2,081
  -2,223
  -2,370
  -2,524
  -2,684
  -2,850
  -3,024
  -3,205
  -3,394
  -3,591
  -3,798
  -4,013
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -327
  -390
  -457
  -529
  -605
  -685
  -769
  -856
  -948
  -1,044
  -1,127
  -1,231
  -1,339
  -1,451
  -1,567
  -1,689
  -1,814
  -1,945
  -2,081
  -2,223
  -2,370
  -2,524
  -2,684
  -2,850
  -3,024
  -3,205
  -3,394
  -3,591
  -3,798
  -4,013

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  8,349
  9,480
  10,683
  11,957
  13,300
  14,711
  16,190
  17,735
  19,347
  21,026
  22,774
  24,592
  26,481
  28,445
  30,485
  32,606
  34,810
  37,102
  39,486
  41,967
  44,550
  47,241
  50,045
  52,968
  56,018
  59,201
  62,525
  65,996
  69,624
  73,417
Adjusted assets (=assets-cash), $m
  8,349
  9,480
  10,683
  11,957
  13,300
  14,711
  16,190
  17,735
  19,347
  21,026
  22,774
  24,592
  26,481
  28,445
  30,485
  32,606
  34,810
  37,102
  39,486
  41,967
  44,550
  47,241
  50,045
  52,968
  56,018
  59,201
  62,525
  65,996
  69,624
  73,417
Revenue / Adjusted assets
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
Average production assets, $m
  3,511
  3,987
  4,493
  5,029
  5,594
  6,188
  6,810
  7,459
  8,137
  8,844
  9,579
  10,343
  11,138
  11,964
  12,822
  13,714
  14,641
  15,605
  16,608
  17,652
  18,738
  19,870
  21,049
  22,279
  23,562
  24,900
  26,298
  27,759
  29,284
  30,880
Working capital, $m
  -163
  -185
  -208
  -233
  -259
  -287
  -316
  -346
  -377
  -410
  -444
  -480
  -516
  -555
  -595
  -636
  -679
  -724
  -770
  -819
  -869
  -921
  -976
  -1,033
  -1,093
  -1,155
  -1,219
  -1,287
  -1,358
  -1,432
Total debt, $m
  5,042
  6,040
  7,102
  8,225
  9,410
  10,655
  11,958
  13,321
  14,743
  16,224
  17,766
  19,369
  21,035
  22,767
  24,567
  26,437
  28,381
  30,403
  32,506
  34,694
  36,972
  39,345
  41,818
  44,397
  47,087
  49,894
  52,826
  55,888
  59,087
  62,433
Total liabilities, $m
  7,363
  8,361
  9,423
  10,546
  11,731
  12,976
  14,279
  15,642
  17,064
  18,545
  20,087
  21,690
  23,356
  25,088
  26,888
  28,758
  30,702
  32,724
  34,827
  37,015
  39,293
  41,666
  44,139
  46,718
  49,408
  52,215
  55,147
  58,209
  61,408
  64,754
Total equity, $m
  985
  1,119
  1,261
  1,411
  1,569
  1,736
  1,910
  2,093
  2,283
  2,481
  2,687
  2,902
  3,125
  3,356
  3,597
  3,847
  4,108
  4,378
  4,659
  4,952
  5,257
  5,574
  5,905
  6,250
  6,610
  6,986
  7,378
  7,788
  8,216
  8,663
Total liabilities and equity, $m
  8,348
  9,480
  10,684
  11,957
  13,300
  14,712
  16,189
  17,735
  19,347
  21,026
  22,774
  24,592
  26,481
  28,444
  30,485
  32,605
  34,810
  37,102
  39,486
  41,967
  44,550
  47,240
  50,044
  52,968
  56,018
  59,201
  62,525
  65,997
  69,624
  73,417
Debt-to-equity ratio
  5.120
  5.400
  5.630
  5.830
  6.000
  6.140
  6.260
  6.370
  6.460
  6.540
  6.610
  6.670
  6.730
  6.780
  6.830
  6.870
  6.910
  6.940
  6.980
  7.010
  7.030
  7.060
  7.080
  7.100
  7.120
  7.140
  7.160
  7.180
  7.190
  7.210
Adjusted equity ratio
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -327
  -390
  -457
  -529
  -605
  -685
  -769
  -856
  -948
  -1,044
  -1,127
  -1,231
  -1,339
  -1,451
  -1,567
  -1,689
  -1,814
  -1,945
  -2,081
  -2,223
  -2,370
  -2,524
  -2,684
  -2,850
  -3,024
  -3,205
  -3,394
  -3,591
  -3,798
  -4,013
Depreciation, amort., depletion, $m
  368
  415
  466
  520
  576
  635
  698
  763
  830
  901
  958
  1,034
  1,114
  1,196
  1,282
  1,371
  1,464
  1,561
  1,661
  1,765
  1,874
  1,987
  2,105
  2,228
  2,356
  2,490
  2,630
  2,776
  2,928
  3,088
Funds from operations, $m
  41
  25
  9
  -9
  -29
  -49
  -71
  -94
  -118
  -143
  -169
  -196
  -225
  -255
  -285
  -317
  -350
  -385
  -421
  -458
  -497
  -537
  -579
  -622
  -668
  -715
  -764
  -816
  -869
  -925
Change in working capital, $m
  -21
  -22
  -23
  -25
  -26
  -28
  -29
  -30
  -31
  -33
  -34
  -35
  -37
  -38
  -40
  -41
  -43
  -45
  -47
  -48
  -50
  -52
  -55
  -57
  -59
  -62
  -65
  -68
  -71
  -74
Cash from operations, $m
  61
  47
  32
  15
  -3
  -22
  -42
  -64
  -86
  -110
  -135
  -161
  -188
  -216
  -245
  -276
  -307
  -340
  -374
  -409
  -446
  -484
  -524
  -565
  -608
  -653
  -699
  -748
  -799
  -851
Maintenance CAPEX, $m
  -306
  -351
  -399
  -449
  -503
  -559
  -619
  -681
  -746
  -814
  -884
  -958
  -1,034
  -1,114
  -1,196
  -1,282
  -1,371
  -1,464
  -1,561
  -1,661
  -1,765
  -1,874
  -1,987
  -2,105
  -2,228
  -2,356
  -2,490
  -2,630
  -2,776
  -2,928
New CAPEX, $m
  -447
  -476
  -506
  -536
  -565
  -594
  -622
  -650
  -678
  -706
  -735
  -765
  -795
  -826
  -858
  -892
  -927
  -964
  -1,003
  -1,044
  -1,086
  -1,132
  -1,179
  -1,230
  -1,283
  -1,339
  -1,398
  -1,460
  -1,526
  -1,595
Cash from investing activities, $m
  -753
  -827
  -905
  -985
  -1,068
  -1,153
  -1,241
  -1,331
  -1,424
  -1,520
  -1,619
  -1,723
  -1,829
  -1,940
  -2,054
  -2,174
  -2,298
  -2,428
  -2,564
  -2,705
  -2,851
  -3,006
  -3,166
  -3,335
  -3,511
  -3,695
  -3,888
  -4,090
  -4,302
  -4,523
Free cash flow, $m
  -692
  -779
  -873
  -970
  -1,070
  -1,175
  -1,283
  -1,395
  -1,510
  -1,630
  -1,755
  -1,883
  -2,017
  -2,156
  -2,300
  -2,450
  -2,606
  -2,768
  -2,937
  -3,114
  -3,298
  -3,490
  -3,690
  -3,900
  -4,119
  -4,348
  -4,587
  -4,838
  -5,100
  -5,375
Issuance/(repayment) of debt, $m
  930
  998
  1,061
  1,124
  1,185
  1,245
  1,304
  1,363
  1,422
  1,481
  1,542
  1,603
  1,666
  1,732
  1,800
  1,870
  1,944
  2,022
  2,103
  2,188
  2,278
  2,373
  2,473
  2,579
  2,690
  2,807
  2,931
  3,062
  3,200
  3,345
Issuance/(repurchase) of shares, $m
  452
  523
  599
  679
  763
  851
  943
  1,039
  1,138
  1,242
  1,333
  1,445
  1,562
  1,683
  1,808
  1,939
  2,075
  2,216
  2,363
  2,516
  2,675
  2,841
  3,014
  3,195
  3,384
  3,581
  3,786
  4,001
  4,226
  4,461
Cash from financing (excl. dividends), $m  
  1,382
  1,521
  1,660
  1,803
  1,948
  2,096
  2,247
  2,402
  2,560
  2,723
  2,875
  3,048
  3,228
  3,415
  3,608
  3,809
  4,019
  4,238
  4,466
  4,704
  4,953
  5,214
  5,487
  5,774
  6,074
  6,388
  6,717
  7,063
  7,426
  7,806
Total cash flow (excl. dividends), $m
  690
  742
  788
  833
  877
  921
  964
  1,007
  1,050
  1,093
  1,120
  1,165
  1,211
  1,259
  1,308
  1,359
  1,413
  1,469
  1,528
  1,590
  1,656
  1,725
  1,797
  1,874
  1,955
  2,040
  2,130
  2,225
  2,325
  2,431
Retained Cash Flow (-), $m
  -452
  -523
  -599
  -679
  -763
  -851
  -943
  -1,039
  -1,138
  -1,242
  -1,333
  -1,445
  -1,562
  -1,683
  -1,808
  -1,939
  -2,075
  -2,216
  -2,363
  -2,516
  -2,675
  -2,841
  -3,014
  -3,195
  -3,384
  -3,581
  -3,786
  -4,001
  -4,226
  -4,461
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  238
  218
  189
  154
  114
  70
  21
  -32
  -89
  -149
  -213
  -280
  -351
  -424
  -500
  -580
  -662
  -747
  -835
  -926
  -1,020
  -1,117
  -1,217
  -1,321
  -1,429
  -1,540
  -1,656
  -1,776
  -1,901
  -2,030
Discount rate, %
  7.30
  7.67
  8.05
  8.45
  8.87
  9.32
  9.78
  10.27
  10.79
  11.32
  11.89
  12.49
  13.11
  13.77
  14.45
  15.18
  15.93
  16.73
  17.57
  18.45
  19.37
  20.34
  21.35
  22.42
  23.54
  24.72
  25.96
  27.25
  28.62
  30.05
PV of cash for distribution, $m
  222
  188
  150
  111
  75
  41
  11
  -15
  -35
  -51
  -62
  -68
  -71
  -70
  -66
  -60
  -54
  -46
  -39
  -31
  -25
  -19
  -14
  -10
  -7
  -5
  -3
  -2
  -1
  -1
Current shareholders' claim on cash, %
  94.8
  89.8
  85.0
  80.5
  76.1
  72.0
  68.2
  64.5
  61.0
  57.7
  54.6
  51.7
  49.0
  46.3
  43.9
  41.5
  39.3
  37.2
  35.2
  33.3
  31.5
  29.8
  28.2
  26.7
  25.3
  23.9
  22.6
  21.4
  20.3
  19.2

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. It delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.

FINANCIAL RATIOS  of  Chemours (CC)

Valuation Ratios
P/E Ratio 1156.6
Price to Sales 1.5
Price to Book 81
Price to Tangible Book
Price to Cash Flow 13.6
Price to Free Cash Flow 31.6
Growth Rates
Sales Growth Rate -5.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -34.9%
Cap. Spend. - 3 Yr. Gr. Rate -5.1%
Financial Strength
Quick Ratio 60
Current Ratio 0
LT Debt to Equity 3529%
Total Debt to Equity 3544%
Interest Coverage 1
Management Effectiveness
Return On Assets -2%
Ret/ On Assets - 3 Yr. Avg. 1.4%
Return On Total Capital 0.2%
Ret/ On T. Cap. - 3 Yr. Avg. 3.2%
Return On Equity 6.2%
Return On Equity - 3 Yr. Avg. 4.4%
Asset Turnover 0.9
Profitability Ratios
Gross Margin 20.6%
Gross Margin - 3 Yr. Avg. 19.5%
EBITDA Margin 8.9%
EBITDA Margin - 3 Yr. Avg. 8.2%
Operating Margin -1.4%
Oper. Margin - 3 Yr. Avg. 1.4%
Pre-Tax Margin -0.2%
Pre-Tax Margin - 3 Yr. Avg. 1.7%
Net Profit Margin 0.1%
Net Profit Margin - 3 Yr. Avg. 1.6%
Effective Tax Rate 163.6%
Eff/ Tax Rate - 3 Yr. Avg. 81%
Payout Ratio 314.3%

CC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the CC stock intrinsic value calculation we used $6183 million for the last fiscal year's total revenue generated by Chemours. The default revenue input number comes from 2017 income statement of Chemours. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our CC stock valuation model: a) initial revenue growth rate of 14.5% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 7.3%, whose default value for CC is calculated based on our internal credit rating of Chemours, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Chemours.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of CC stock the variable cost ratio is equal to 101.4%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for CC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.6% for Chemours.

Corporate tax rate of 27% is the nominal tax rate for Chemours. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the CC stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for CC are equal to 49.6%.

Life of production assets of 10 years is the average useful life of capital assets used in Chemours operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for CC is equal to -2.3%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $860 million for Chemours - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 185 million for Chemours is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Chemours at the current share price and the inputted number of shares is $8.2 billion.

RELATED COMPANIES Price Int.Val. Rating
MMM 3M 200.52 175.63  hold
HUN Huntsman 31.86 87.76  str.buy
KRO Kronos Worldwi 20.38 353.69  str.buy
OXY Occidental Pet 79.66 180.20  str.buy
HON Honeywell Inte 154.13 140.49  hold

COMPANY NEWS

▶ The Key to Spotting a Value Trap   [Aug-09-18 10:31AM  Zacks]
▶ Here's Why Chemours Co. Gained as Much as 11.4% Today   [Aug-03-18 02:27PM  Motley Fool]
▶ Chemours Co. to Host Earnings Call   [06:30AM  ACCESSWIRE]
▶ Chemours: 2Q Earnings Snapshot   [05:12AM  Associated Press]
▶ 4 Reasons To Be Buyers Of Chemours, Courtesy Of RBC   [Jul-18-18 03:32PM  Benzinga]
▶ Why This Analyst Likes Chemours Stock   [11:22AM  Motley Fool]
▶ Chemical Production on the Upswing: 5 Growth Stocks to Buy   [Jul-06-18 11:10AM  InvestorPlace]
▶ Chemours Company Enters Oversold Territory   [Jun-22-18 07:12AM  Zacks]
▶ 5 Value Stocks for Market-Beating Returns   [Jun-20-18 01:25PM  InvestorPlace]
▶ Top Ranked Growth Stocks to Buy for May 29th   [May-29-18 09:27AM  Zacks]
▶ 5 Ultra Cheap PEG Stocks Value Investors Will Love   [May-15-18 12:15PM  InvestorPlace]
▶ Chemours Announces Sodium Cyanide Price Increase   [May-07-18 04:45PM  PR Newswire]
▶ Chemours Co. to Host Earnings Call   [06:00AM  ACCESSWIRE]
▶ Chemours: 1Q Earnings Snapshot   [05:03AM  Associated Press]
▶ Chemours Announces Second Quarter Dividend   [May-01-18 08:48PM  PR Newswire]
▶ 'Fast and loose': Plaintiffs respond to motion to dismiss GenX case   [Apr-16-18 02:25PM  American City Business Journals]
▶ 5 Great Basic Materials Stocks to Buy Ahead of Q1 Earnings   [Apr-10-18 01:15PM  InvestorPlace]
▶ Ex-DuPont workers say Chemours Co. tricked them out of money   [Apr-06-18 07:01AM  Associated Press]
▶ Top Ranked Value Stocks to Buy for April 5th   [Apr-05-18 06:40AM  Zacks]
▶ Chemours Announces Fluoropolymer Price Increase   [Mar-29-18 05:28PM  PR Newswire]
▶ Teflon maker Chemours sees more profit in 2018   [Mar-26-18 05:14PM  MarketWatch]
▶ Top Ranked Value Stocks to Buy for March 16th   [Mar-16-18 07:50AM  Zacks]
▶ Top Ranked Value Stocks to Buy for March 12th   [Mar-12-18 07:06AM  Zacks]
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.